文献速递针灸推拿中医康复

针刺选择对战场耳穴针灸耐受性与镇痛效果的探索性随机对照试验

Effect of needle selection on battlefield acupuncture tolerance and pain reduction: an exploratory randomized controlled trial.
PubMed 文献 · Acupunct Med · 2025-11-29

本研究为一项非盲探索性随机对照试验,纳入30例急性或慢性疼痛患者,随机分为ASP针、15mm一次性针和Pyonex针三组(每组10例),评估不同针具对耳穴战场针灸(BFA)耐受性和疼痛缓解的差异。结果显示15mm针的针刺部位疼痛耐受性低于ASP针(OR=0.12,p=0.005),而Pyonex与ASP无显著差异;所有组DVPRS评分在治疗后显著下降(β=-1.40,p<0.001),组间无显著交互作用。

要点

  • 15mm针的针刺部位疼痛耐受性低于ASP针(OR=0.12,p=0.005)。
  • 所有BFA针具组治疗后DVPRS评分均显著下降(β=-1.40,p<0.001)。
  • 三种针具在患者满意度、头晕、瘀斑、疲劳或头痛方面无显著差异(p=0.190)。

核心结论

  • 比较BFA不同针具类型是可行的,且干预措施为受试者所接受。
  • 15mm针的针刺部位疼痛耐受性低于ASP针,而Pyonex与ASP无显著差异。
  • 所有治疗组DVPRS评分均显著下降,但组间无显著交互作用。

研究设计与样本

  • 非盲、探索性随机对照试验,纳入30例主诉急性或慢性疼痛的患者。
  • 随机分为ASP针组、15mm一次性针组和Pyonex针组,每组10例。
  • 使用随机效应回归和有序逻辑模型评估DVPRS评分和针具耐受性问卷。

主要发现

  • 针刺部位疼痛耐受性组间差异有统计学意义(p=0.002),15mm针低于ASP针(OR=0.12,p=0.005),Pyonex与ASP无显著差异(OR=1.45,p=0.525)。
  • 患者总体满意度、头晕、瘀斑、疲劳或头痛在三组间无显著差异(p=0.190)。
  • 治疗组与临床特征之间无统计学显著关联(均p>0.05)。
  • 治疗后DVPRS总分显著下降(交互β=-1.40,p<0.001),DVPRS问题1(β=-1.23,p=0.003)、3(β=-1.23,p<0.002)和4(β=-1.10,p=0.002)也下降。
  • 治疗后DVPRS问题1(β=-0.15,p=0.014)、3(β=-0.12,p=0.049)和4(β=-0.13,p=0.016)随时间下降,但总分无显著时间效应;未观察到治疗组显著交互作用。

临床怎么用

  • 对于接受BFA的患者,选择15mm针可能减少针刺部位疼痛耐受性问题。
  • BFA可用于急性或慢性疼痛患者,且不同针具均显示一定镇痛效果。
  • 临床可根据患者耐受性偏好选择针具类型,但需进一步大样本研究确认差异。

局限性

  • 探索性研究样本量小(30例),统计效能有限。
  • 研究为非盲设计,可能存在偏倚。
  • 事后功效计算提示需更大样本量才能更明确评估不同针具的镇痛效果差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There has been limited research comparing the different types of needles used for auricular battlefield acupuncture (BFA). The aim of this exploratory study was to determine the feasibility of examining whether there are differences in needle tolerance and/or pain reduction between different needle types. METHODS: We conducted an unblinded, exploratory, randomized controlled trial in human subjects with complaints of acute or chronic pain. We randomized 30 patients to receive BFA with ASP needles, disposable needles of 15 mm length or Pyonex needles (n = 10 per group). Differences in Defense and Veteran Pain Rating Scale (DVPRS) scores and needle tolerance questionnaire responses by treatment group and follow-up time point (baseline, 10 min, 24 h and 1 week) were assessed using random effects regression and ordinal logistics models. RESULTS: A difference in needle tolerance by treatment group was observed for pain at the site(s) of needling (p = 0.002), which was lower for 15-mm needles (odds ratio (OR) = 0.12, p = 0.005) than for ASP needles, but not significantly different for Pyonex versus ASP (OR = 1.45, p = 0.525). There were no difference in overall patient satisfaction, dizziness, bruising, fatigue or headaches between the three BFA needle groups (p = 0.190). No statistically significant associations were observed between treatment group and clinical characteristics (all p > 0.05). DVPRS scores significantly declined after treatment (interaction beta coefficient (β) = -1.40, p < 0.001) across all treatment groups. Declines were also observed post treatment for DVPRS questions 1 (β = -1.23, p = 0.003), 3 (β = -1.23, p < 0.002) and 4 (β = -1.10, p = 0.002). A decline over time after treatment was also observed for DVPRS question 1 (β = -0.15, p = 0.014), 3 (β = -0.12, 0.049) and 4 (β = -0.13, p = 0.016) but was not DVPRS overall score. No significant interactions by treatment group were observed. CONCLUSION: Testing BFA needle types against each other was feasible and the interventions were acceptable to subjects. Through a post hoc power calculation, this study provides a greater understanding of the number of patients that would be needed to more definitively assess for potential differences in effectiveness (pain reduction) between various types of needles in BFA. TRIAL REGISTRATION NUMBER: NCT04464954 (ClinicalTrials.gov).

来源:Acupunct Med,查看原文。版权归原作者所有。

引用

  1. Burton SJ, Moss DA, Crawford PF, et al. Effect of needle selection on battlefield acupuncture tolerance and pain reduction: an exploratory randomized controlled trial. Acupunct Med. 2025. PMID: 41317090. doi:10.1177/09645284251400386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。